While ATR inhibition or ablative radiotherapy alone had a limited effect on lung tumor progression, the combination of ATR inhibition and ablative radiotherapy significantly reduced the metastatic tumor burden in non-irradiated lung regions (P < 0.05) than that in the control group. This evidence concerns the gene ATR and metastatic neoplasm.